• Home
  • About Us
  • Solutions
    • Industries
      • Phamaceuticals
      • BioTech
      • AgTech
      • Cannabis
      • CBD-Hemp
      • Technology
    • Advisory
      • Turn Around & Transformation
      • Board Member Recruitment
      • PPMs, CIMs, Executive Summaries and Pitch Decks
      • Financial Modeling and Capital Planning
      • Product Commercialization
      • Cannabis Business Advisory
  • Access to Capital
    • Debt Funding
      • MTN
    • M&A
  • Canna-Hemp Debt Fund
    • Cannabis Capital Markets
    • The Fund
  • Insights
    • Blog33
    • The Edge Newsletters
    • News & Events
    • Tracking Smart Money
Let’s Talk
highwaylogoheader-1
  • Home
  • About Us
  • Solutions
    • Industries
      • Phamaceuticals
      • BioTech
      • AgTech
      • Cannabis
      • CBD-Hemp
      • Technology
    • Advisory
      • Turn Around & Transformation
      • Board Member Recruitment
      • PPMs, CIMs, Executive Summaries and Pitch Decks
      • Financial Modeling and Capital Planning
      • Product Commercialization
      • Cannabis Business Advisory
  • Access to Capital
    • Debt Funding
      • MTN
    • M&A
  • Canna-Hemp Debt Fund
    • Cannabis Capital Markets
    • The Fund
  • Insights
    • Blog33
    • The Edge Newsletters
    • News & Events
    • Tracking Smart Money
U.S. Cannabis Market to be Worth $40.0 Billion by 2030: Grand View Research, Inc.

U.S. Cannabis Market to be Worth $40.0 Billion by 2030: Grand View Research, Inc.

July 29, 2022
Schumer's legal weed bill is finally here

Schumer’s legal weed bill is finally here

July 29, 2022
First Quarter 2022 Capital Markets Review: Debt Financing Remains Dominant Source of Funding

First Quarter 2022 Capital Markets Review: Debt Financing Remains Dominant Source of Funding

July 22, 2022
Cannabis Market Profile – Massachusetts

The 15 Largest Cannabis Companies In The World

July 22, 2022
Will a looming recession sink the cannabis industry, or will it stay afloat?

Will a looming recession sink the cannabis industry, or will it stay afloat?

July 18, 2022
Pennsylvania Governor Signs Cannabis Banking Legislation Into Law

Pennsylvania Governor Signs Cannabis Banking Legislation Into Law

July 18, 2022
For Cannabis Consumers, Inflation is No Obstacle

For Cannabis Consumers, Inflation is No Obstacle

July 18, 2022
Convenience store giant to boost stake in marijuana retailer Fire & Flower

Canada’s adult-use cannabis sales rebound to record CA$372 million in April

June 24, 2022
Maines Legal Marijuana Stores Are Effectively Displacing Illicit Market, State Report Finds

Maine’s Legal Marijuana Stores Are Effectively Displacing Illicit Market, State Report Finds

June 17, 2022
Marijuana Legalization Linked To Decreased Use Of Alcohol, Nicotine And Opioids, New Study Finds

Marijuana Legalization Linked To Decreased Use Of Alcohol, Nicotine And Opioids

June 10, 2022
Momentum for Federal Legalization of Cannabis Shifts Toward Incrementalism

Cannabis Conference Abuzz with Anticipation for New York’s Adult-Use Market

June 10, 2022

Posts pagination

< Page 1 Page 2 Page 3 Page 4 … Page 11 >
Search
Recent Posts
Press Release: President Trump Signals Marijuana Rescheduling Decision Imminent
Press Release: President Trump Signals Marijuana Rescheduling Decision Imminent
August 14, 2025
Hemp vs. CBD Investments: Which Path Offers More Strategic Value?
Hemp vs. CBD Investments: Which Path Offers More Strategic Value?
July 29, 2025
What Do Cannabis Investment Banks Really Offer Strategic Investors?
What Do Cannabis Investment Banks Really Offer Strategic Investors?
July 29, 2025
Categories
  • Blog
  • Highway Edge: Biotech
  • Highway Edge: Cannabis
  • Highway Edge: Pharma
  • Highway Edge: Technology
  • News
Highway 33 Capital Advisory Logo

Buy side. Sell side. Your side.

Get in Touch
MIAMI - DENVER - DETROIT - SAN FRANCISCOEmail: info@highway33.comPhone: +1 (800) 684-9238
Subscribe


    I have read and agree to the terms & conditions

    Highway 33 Capital Advisory © 2025. All rights reserved.

    • Privacy Policy
    • SEC FINRA Disclaimer